The MUHC Research Ethics Board (REB) is the evaluating body for ethical and scientific review at this institution.
The MUHC REB reviews all research involving humans under its auspice, to help ensure it meets the required ethical and scientific standards.
- There is one MUHC REB and 6 specialised panels
- The 6 specialised panels will conduct both Science and Ethics review and will meet twice a month on average;
- Submission deadlines are abolished;
The CAE staff will conduct pre-reviews of all studies to ensure
- completeness,
- minimal quality of documents submitted and
- assess level of risk and initiate delegated review of minimal risk studies (instead of full board reviews).
The MUHC currently has a single REB with 6 specialized panels :
- PED
- NEUPSY
- CT1 (Oncology)
- CT2
- CT3
- CTGQ
6 Panels of the MUHC-REB
Pediatrics (PED):
Clinical Trials 1 (CT1):
Cells, tissues, genetics & qualitative research (CTGQ):
| Neurosciences-Psychiatry (NEUPSY):
Clinical Trials 2 (CT2): |
Schedule of REB FULL BOARD meetings
For the schedule of REB full board meetings, please see the calendar page on Nagano. Note that studies that are more than minimal risk are reviewed by the full board.
Please enter your study in Nagano as soon as possible to initiate the review process.
Delegated Reviews
Delegated reviews are conducted on an ongoing basis for minimal risk studies.
MUHC REB Chair: Marie Hirtle | ||
| Panels | Co-Chairs: | REB Coordination |
| PEDS | Carlo Cicero | Ms. Elizabeth Craven |
| NEUPSY | Dr. Serge Gauthier, Dr. Simon Ducharme | Ms. Bonnie McKeating |
| CT1 | Mr. Vincent Lajoie | Ms. Elizabeth Craven |
| CT2 | Ms. Franca Cantini, Dr. Alan Sniderman | Ms. Sonia Cantini |
| CT3 | Ms. Sonya Page, Dr. Ronald Olivenstein | Ms. Farah Youssef |
| CTGQ | Me Marie Hirtle | Mr. James Ellasus |
Other REB Co-Chairs: Me Brigitte Paquet, Mr. Renaud Boulanger
Other REB Coordinator: Ms Joanne Lebrasseur
For panel contact information click here.
Updated May 14, 2025